Tetra Bio Pharma Inc TBPMQ
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.03
- Bid/Ask
- $0.00 / $0.00
- Market Cap
- $423.36
- Volume/Avg
- 53,000 / 23,367
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Tetra Bio Pharma Inc is a biopharmaceutical leader in cannabinoid-based drug. It discovers and develops clinical programs aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. The company with its subsidiaries engaged in the development of an advanced and growing pipeline of Bio Pharmaceuticals and Veterinary Products containing cannabinoids. Tetra Bio-Pharma is focused on providing rigorous scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators, physicians and insurance companies.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 33
- Website
- https://www.tetrabiopharma.com
Valuation
|
Metric
|
TBPMQ
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
TBPMQ
Financial Strength
|
Metric
|
TBPMQ
|
|---|---|
Quick Ratio | 0.23 |
Current Ratio | 0.25 |
Interest Coverage | −77.61 |
Quick Ratio
TBPMQ
Profitability
|
Metric
|
TBPMQ
|
|---|---|
Return on Assets (Normalized) | 125.46% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | 223.23% |
Return on Assets
TBPMQ
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Novo Nordisk A/S ADR
NVO
| Wvrdqrqpw | Ygcb | $635.4 Bil | |||
| Vertex Pharmaceuticals Inc
VRTX
| Wqtgcjqw | Lnhvj | $124.1 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Gnfvymdz | Blrbtb | $114.2 Bil | |||
| Moderna Inc
MRNA
| Xbytrvpyw | Pxhmh | $53.7 Bil | |||
| argenx SE ADR
ARGX
| Fvnpplzq | Fprd | $23.0 Bil | |||
| BioNTech SE ADR
BNTX
| Ptxkkvhd | Nvg | $22.2 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Gsjswbz | Wwckhj | $20.3 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Jrmtbgf | Kxlzh | $15.9 Bil | |||
| United Therapeutics Corp
UTHR
| Nxfsfqz | Zxq | $12.8 Bil | |||
| Incyte Corp
INCY
| Gknsfjd | Nbzfxh | $12.2 Bil |